key: cord-1006647-7bt0514u authors: Sorbello, Massimiliano; Di Giacinto, Ida; Corso, Ruggero M.; Cataldo, Rita title: Prevention is better than the cure, but the cure cannot be worse than the disease date: 2020-04-27 journal: Br J Anaesth DOI: 10.1016/j.bja.2020.04.069 sha: 8212f52991ddb1fa55c012a51ce092f093a9d655 doc_id: 1006647 cord_uid: 7bt0514u nan Prevention is better than the cure, but the cure cannot be worse than the disease Massimiliano 2) "Rapid-sequence fibreoptic bronchoscopic tracheal intubation" 1 4) The authors report that "During attempts at tracheal intubation, HFNO was maintained for the HFNO group", 1 but they don't clarify if intubation was performed by the nasal or oral route. In the first case, either the 4.5 mm fibrescope was inserted in the nostril together with the HFNO prong (thus resulting in difficult scope movement) or in place of the HFNO prongs. Fibreoptic intubation is known to be more challenging via the oral route in anaesthetized patients due to airway collapse, especially if a dedicated airway is not used. 6 If the nasal route was chosen, removing the HFNO prongs to allow passage of the bronchoscope would have reduced the benefit of apnoeic HFNO and increased aerosolization risk. 2, 7-9 5) Despite being superior in preventing hypoxaemia during rapid sequence induction and intubation HFNO is not recommended in COVID-19 patients 2,8-9 since (awake) fibreoptic intubation is considered an aerosol-generating procedure. It is then paradoxical to state that "Rapid-sequence fibreoptic bronchoscopic tracheal intubation in patients with COVID19 pneumonia may reduce the risk of viral spread" 1 , especially if the declared advantage is "an increase of the distance between anaesthesiologist and patient's airway". 1 Bronchoscopes with an average length of 65 cm do not allow the 1 m distance considered safe for airborne spreading. 2, [7] [8] [9] A videolaryngoscope (especially with external screen), works with similar distance but has been shown to be faster and to require lower skills 4 , and to have simpler options for rescue intervention 1,2 . The same message comes from the Chinese experience 6 and from worldwide recommendations. 2, 8, 9 In order to maximise first pass success, we recommend a preloaded bougie or stylet, rapid sequence induction with full dose neuromuscular blockade, preoxygenation by continuation of ongoing noninvasive ventilation, and apnoeic low-flow (1-3 L min -1 ) oxygen through standard nasal prongs (NODESAT). 2 patients. Awake fibreoptic intubation remains the gold-standard for predicted intubation/ventilation difficulty, to be used in very selected cases in COVID-19 patients. 2, [8] [9] Oxygenation, independently of disease, remains the main target of any airway management strategy, 5 and though difficult at times, science and good sense should always prevail. MS has received paid consultancy from Teleflex Medical, Verathon Medical and DEAS Italia, is a patent co-owner (no royalties, DEAS Italia), and has received lecture grants and travel reimbursements (MSD Italia, MSD USA). IDG has received lecture grants and travel reimbursements from MSD Italia. No other competing interests declared. High-flow nasal-oxygenationassisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial and on behalf of The Società Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI) Airway Research Group, and The European Airway Management Society. The Italian coronavirus disease 2019 outbreak: experiences and recommendations from clinical practice Device or target? A paradigm shift in airway management: implications for guidelines, clinical practice and teaching Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience Rocuronium versus succinylcholine for rapid sequence induction intubation Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients Outbreak of a new coronavirus: what anaesthetists should know